Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812795 · ClinicalTrials.gov registry record · NA
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
A NA study of Cigarette Smoking Behavior, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,214
- Enrollment target
- 2
- Study locations
NCT04812795 is a NA study of Cigarette Smoking Behavior that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2,214 participants, above the 435-participant average among 4 other Cigarette Smoking Behavior trials with a reported enrollment target (409% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04812795, a NA study of Cigarette Smoking Behavior, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,214 participants
- Enrollment target
- 2
- Study locations
Study Summary
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.
Conditions Studied
Interventions
- OTHER Culturally tailored anti-smoking messages
- OTHER Non-culturally tailored interventions
Study Locations (2)
California
- Stanford University - Stanford
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,214 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2022-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04812795
The ClinicalTrials.gov registry entry for NCT04812795 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,214 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 435-participant average among 4 other Cigarette Smoking Behavior trials with a reported enrollment target (409% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cigarette Smoking Behavior appearing as the primary indexed condition, and to 2 interventions - of which Culturally tailored anti-smoking messages is the first listed.
NCT04812795 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04812795 about?
NCT04812795 is a clinical study titled "Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches". Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support late...
What is the current status of trial NCT04812795?
This trial is currently completed. It is a NA study. The enrollment target is 2,214 participants. The study started on 2021-09-08. Estimated completion is 2022-06-20.
What conditions does trial NCT04812795 study?
This clinical trial studies the following conditions: Cigarette Smoking Behavior.
What interventions are being tested in trial NCT04812795?
The interventions under investigation include: Culturally tailored anti-smoking messages (OTHER), Non-culturally tailored interventions (OTHER).
Who is sponsoring clinical trial NCT04812795?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04812795 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
RECRUITING · NA
-
An Experimental Evaluation of Menthol-Flavored Tobacco Accessories
ACTIVE NOT RECRUITING · NA
-
Enhancing Source Credibility in Tobacco Regulatory Communications
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.